These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31488568)

  • 1. Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017.
    van den Boom L; Karges B; Auzanneau M; Rami-Merhar B; Lilienthal E; von Sengbusch S; Datz N; Schröder C; Kapellen T; Laimer M; Schmid SM; Müller H; Wolf J; Holl RW
    Diabetes Care; 2019 Nov; 42(11):2050-2056. PubMed ID: 31488568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes.
    Bohn B; Karges B; Vogel C; Otto KP; Marg W; Hofer SE; Fröhlich-Reiterer E; Holder M; Plamper M; Wabitsch M; Kerner W; Holl RW;
    PLoS One; 2016; 11(8):e0160971. PubMed ID: 27532627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.
    Lawson ML; Bradley B; McAssey K; Clarson C; Kirsch SE; Mahmud FH; Curtis JR; Richardson C; Courtney J; Cooper T; Downie CJ; Rajamannar G; Barrowman N; ;
    BMC Pediatr; 2014 Jul; 14():183. PubMed ID: 25034216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
    Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
    JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
    Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
    J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria.
    Ludwig-Seibold CU; Holder M; Rami B; Raile K; Heidtmann B; Holl RW; ; ;
    Pediatr Diabetes; 2012 Feb; 13(1):12-4. PubMed ID: 22128781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry.
    Kamrath C; Tittel SR; Kapellen TM; von dem Berge T; Heidtmann B; Nagl K; Menzel U; Pötzsch S; Konrad K; Holl RW
    Lancet Child Adolesc Health; 2021 Jan; 5(1):17-25. PubMed ID: 33253630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes.
    Bode BW; Kaufman FR; Vint N
    Diabetes Technol Ther; 2017 Mar; 19(3):145-154. PubMed ID: 28135116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Pump and CGM Usage in the United States and Germany: Results of a Real-World Survey With 985 Subjects.
    Walsh J; Roberts R; Weber D; Faber-Heinemann G; Heinemann L
    J Diabetes Sci Technol; 2015 Jun; 9(5):1103-10. PubMed ID: 26071425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
    Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
    Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics Between 2016 and 2019 in Germany.
    Auzanneau M; Rosenbauer J; Maier W; von Sengbusch S; Hamann J; Kapellen T; Freckmann G; Schmidt S; Lilienthal E; Holl RW
    J Diabetes Sci Technol; 2021 Sep; 15(5):1059-1068. PubMed ID: 34253084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.